LIVE: Covaxin Phase 3 Trials Efficacy At 81 Per Cent, Says Bharat Biotech

https://ift.tt/30ecnxO https://ift.tt/eA8V8J March 04, 2021 at 05:14AM https://ift.tt/3kn7Fqd is 81 per cent effective in preventing Covid and can work against the UK variant of the virus, Bharat Biotech said Wednesday as it revealed a "first interim analysis" of Phase III trial...

from NDTV News - Special https://ift.tt/30ecnxO
via IFTTT